Genyous Biomed

Alliances

Invitation to Form Strategic Alliance to Reduce Suffering Due to Deadly COPD and Lung Cancer

Genyous Biomed International (“Genyous”) was founded in 2000 by a group of practical visionaries who seek to significantly improve the methods used to address the growing burden that lung diseases are placing on society. Genyous is committed to developing an affordable and well-tolerated integrated healthcare solution comprised of early detection and a new class multivalent of drugs (patents pending) intended for prevention, early intervention and treatment of deadly lung diseases such as Chronic Obstructive Pulmonary Disease (“COPD”) and lung cancer. Each year over 170,000 Americans are diagnosed with lung cancer and more than 160,000 people die from it. An estimated… READ MORE

Genyous Initiatives to Reduce Suffering Due to Prostate Disorders (Prostatitis, BPH, PIN, HGPIN and Cancer)

Genyous Biomed International (“Genyous”) was founded in 2000 by a group of practical visionaries who seek to significantly improve the methods used to address the growing burden that prostate cancer is placing on society. Genyous is committed to developing an affordable and well-tolerated integrated healthcare solution comprised of early detection and diagnostics coupled with a new class of multivalent pharmaceuticals intended for prevention, early intervention and treatment of heterogeneous prostate disorders including prostatitis, BPH, PIN, HGPIN and prostate cancer. Genyous commercializes its products by licensing to spin off companies and pharmaceutical companies that focus on the unique business characteristics of… READ MORE

Genyous Initiatives to Accelerate Translational Research Through A New Clinical Trials Paradigm

Tumor Tissue Needed for Translational Research Since the decoding of the human genome understanding of the complexity of human biology has grown significantly. With a more detailed understanding of the biological building blocks called genes and proteins, and their intricate signaling pathways (see Figure 1), we have found that diseases such as cancer are much more complex and heterogeneous than previously thought. With the growing appreciation for the heterogeneous nature of cancer, it is becoming increasingly apparent that, in stark contrast to early practices of one size fits all, future improvements… READ MORE